Portfolio company
Evvy
United States · £31.6m raised
Raised
£31.6m
Latest stage
Series B
Rounds recorded
1
Backed by
3 investors
Sectors
About
Evvy provides at-home vaginal microbiome testing and clinical care services for women and people with vaginas to manage infections and reproductive health.
SourceFunding history · 1
Similar companies
Winx Health
This company provides at-home testing kits, treatments and educational resources for vaginal, urinary and reproductive health to female consumers.
TBD HEALTH
This company provides at-home screening kits and clinical services for sexually transmitted infections to individuals seeking private sexual healthcare.
Tiny Health
The company provides at-home gut and vaginal microbiome testing kits and analysis for babies, children, adults, and healthcare practitioners.
Daye
Daye produces organic tampons, pads, and at-home vaginal health screening kits for women and individuals assigned female at birth.
Nanopath
This company develops point-of-care molecular diagnostic tests and hardware for pelvic and gynecologic infections to provide rapid results for healthcare providers and their patients.
MyUTI
This company provides diagnostic laboratory testing kits and telehealth services for individuals suffering from urinary tract infections and related pelvic health issues.
Viome
Viome provides at-home RNA testing kits and personalised nutritional supplements to help health-conscious consumers and patients improve their microbiome health and overall wellbeing.
P.Happi
This company develops a microbiome-based intimate serum designed to protect women from recurring discomfort and bad bacteria.
